Citeline Scrip Asia 100 Report: The Japanese Pharma Market in 2025 & Beyond
CMIC Group was recently featured in Citeline’s “Scrip Asia 100 Report”. Access the free pdf to read our full featured article.
“The Japanese Pharma Market in 2025 & Beyond: Insights from CMIC’s Dr. Yoshimasa Shimoto”
Dr. Yoshimasa Shimoto, a seasoned expert in Japan’s pharmaceutical landscape, shares his insights into the unique aspects of the Japanese pharma market and its appeal to international companies. With a wealth of experience throughout his career, Dr. Shimoto now leads the strategic Consulting & Navigation Unit as a Co-Partner at CMIC. In this article, he discusses recent regulatory updates, key opportunities, and challenges overseas businesses should consider when entering the Japanese clinical development space.
Copyright ©️ 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company
